1. Home
  2. XBIT vs QBTS Comparison

XBIT vs QBTS Comparison

Compare XBIT & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIT
    SELLHOLDBUYas of 17 hours ago
  • QBTS
    SELLHOLDBUYas of 17 hours ago
  • Stock Information
  • Founded
  • XBIT 2005
  • QBTS 1999
  • Country
  • XBIT United States
  • QBTS Canada
  • Employees
  • XBIT N/A
  • QBTS N/A
  • Industry
  • XBIT Pharmaceuticals and Biotechnology
  • QBTS Retail: Computer Software & Peripheral Equipment
  • Sector
  • XBIT Health Care
  • QBTS Technology
  • Exchange
  • XBIT Nasdaq
  • QBTS Nasdaq
  • Market Cap
  • XBIT 194.5M
  • QBTS 194.5M
  • IPO Year
  • XBIT 2015
  • QBTS N/A
  • Fundamental
  • Price
  • XBIT $4.01
  • QBTS $6.10
  • Analyst Decision
  • XBIT
  • QBTS Strong Buy
  • Analyst Count
  • XBIT 0
  • QBTS 6
  • Target Price
  • XBIT N/A
  • QBTS $5.63
  • AVG Volume (30 Days)
  • XBIT 102.7K
  • QBTS 97.4M
  • Earning Date
  • XBIT 11-13-2024
  • QBTS 11-14-2024
  • Dividend Yield
  • XBIT N/A
  • QBTS N/A
  • EPS Growth
  • XBIT N/A
  • QBTS N/A
  • EPS
  • XBIT N/A
  • QBTS N/A
  • Revenue
  • XBIT N/A
  • QBTS $9,424,000.00
  • Revenue This Year
  • XBIT N/A
  • QBTS $4.86
  • Revenue Next Year
  • XBIT N/A
  • QBTS $64.04
  • P/E Ratio
  • XBIT N/A
  • QBTS N/A
  • Revenue Growth
  • XBIT N/A
  • QBTS 14.27
  • 52 Week Low
  • XBIT $3.51
  • QBTS $0.68
  • 52 Week High
  • XBIT $9.96
  • QBTS $11.41
  • Technical
  • Relative Strength Index (RSI)
  • XBIT 31.35
  • QBTS 46.76
  • Support Level
  • XBIT $3.72
  • QBTS $7.80
  • Resistance Level
  • XBIT $4.67
  • QBTS $10.58
  • Average True Range (ATR)
  • XBIT 0.52
  • QBTS 1.87
  • MACD
  • XBIT -0.06
  • QBTS -0.24
  • Stochastic Oscillator
  • XBIT 15.11
  • QBTS 21.43

Stock Price Comparison Chart: XBIT vs QBTS

â–  XBIT
â–  QBTS
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022XBIT VS QBTS

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is engaged in the development and delivery of quantum computing systems, software, and services, and is the commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modelling. D-Wave's annealing quantum computers are accessible through the Company's LeapTM cloud service.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use